Elanco Animal Health (ELAN)
NYSE:ELAN
Want to see ELAN full AI Analyst Report?
Total Valuation
Elanco Animal Health has a market cap or net worth of $10.85B. The enterprise value is $14.42B.
Market Cap$10.85B
Enterprise Value$14.42B
Share Statistics
Elanco Animal Health has 499,449,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding499,449,600
Owned by Insiders0.97%
Owned by Institutions18.46%
Financial Efficiency
Elanco Animal Health’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is 2.13%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)2.13%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee523.89K
Profits Per Employee-25.78K
Employee Count9,000
Asset Turnover0.35
Inventory Turnover1.53
Valuation Ratios
The current PE Ratio of Elanco Animal Health is 52.2. Elanco Animal Health’s PEG ratio is 0.29.
PE Ratio52.2
PS Ratio2.38
PB Ratio1.72
Price to Fair Value1.72
Price to FCF39.55
Price to Operating Cash Flow18.74
PEG Ratio0.29
Income Statement
In the last 12 months, Elanco Animal Health had revenue of 4.71B and earned -232.00M in profits. Earnings per share was -0.47.
Revenue4.71B
Gross Profit2.05B
Operating Income252.00M
Pretax Income-224.00M
Net Income-232.00M
EBITDA676.00M
Earnings Per Share (EPS)-0.47
Cash Flow
In the last 12 months, operating cash flow was 577.00M and capital expenditures -262.00M, giving a free cash flow of 315.00M billion.
Operating Cash Flow577.00M
Free Cash Flow315.00M
Free Cash Flow per Share0.63
Dividends & Yields
Elanco Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.14
52-Week Price Change71.64%
50-Day Moving Average22.99
200-Day Moving Average22.06
Relative Strength Index (RSI)47.83
Average Volume (3m)6.12M
Important Dates
Elanco Animal Health upcoming earnings date is Aug 10, 2026, Before Open (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateAug 10, 2026
Ex-Dividend Date―
Financial Position
Elanco Animal Health as a current ratio of 2.17, with Debt / Equity ratio of 61.40%
Current Ratio2.17
Quick Ratio1.08
Debt to Market Cap0.36
Net Debt to EBITDA5.14
Interest Coverage Ratio1.15
Taxes
In the past 12 months, Elanco Animal Health has paid 8.00M in taxes.
Income Tax8.00M
Effective Tax Rate-0.04
Enterprise Valuation
Elanco Animal Health EV to EBITDA ratio is 21.75, with an EV/FCF ratio of 51.78.
EV to Sales3.12
EV to EBITDA21.75
EV to Free Cash Flow51.78
EV to Operating Cash Flow26.26
Balance Sheet
Elanco Animal Health has $428.00M in cash and marketable securities with $3.99B in debt, giving a net cash position of -$3.56B billion.
Cash & Marketable Securities$428.00M
Total Debt$3.99B
Net Cash-$3.56B
Net Cash Per Share-$7.13
Tangible Book Value Per Share-$3.30
Margins
Gross margin is 49.44%, with operating margin of 5.34%, and net profit margin of -4.92%.
Gross Margin49.44%
Operating Margin5.34%
Pretax Margin-4.75%
Net Profit Margin-4.92%
EBITDA Margin14.34%
EBIT Margin-0.08%
Analyst Forecast
The average price target for Elanco Animal Health is $28.43, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$28.43
Price Target Upside20.05% Upside
Analyst ConsensusStrong Buy
Analyst Count11
Revenue Growth Forecast10.53%
EPS Growth Forecast-164.58%